![Frontiers | Extracellular Vesicle Associated miRNAs Regulate Signaling Pathways Involved in COVID-19 Pneumonia and the Progression to Severe Acute Respiratory Corona Virus-2 Syndrome | Immunology Frontiers | Extracellular Vesicle Associated miRNAs Regulate Signaling Pathways Involved in COVID-19 Pneumonia and the Progression to Severe Acute Respiratory Corona Virus-2 Syndrome | Immunology](https://www.frontiersin.org/files/Articles/784028/fimmu-12-784028-HTML-r1/image_m/fimmu-12-784028-g001.jpg)
Frontiers | Extracellular Vesicle Associated miRNAs Regulate Signaling Pathways Involved in COVID-19 Pneumonia and the Progression to Severe Acute Respiratory Corona Virus-2 Syndrome | Immunology
![Update on the use of 13-valent pneumococcal conjugate vaccine (PNEU-C-13) in addition to 23-valent pneumococcal polysaccharide vaccine (PNEU-P-23) in immunocompetent adults 65 years of age and older – Interim Recommendation - Canada.ca Update on the use of 13-valent pneumococcal conjugate vaccine (PNEU-C-13) in addition to 23-valent pneumococcal polysaccharide vaccine (PNEU-P-23) in immunocompetent adults 65 years of age and older – Interim Recommendation - Canada.ca](https://www.canada.ca/content/dam/phac-aspc/images/services/publications/healthy-living/update-use-of-13-valent-pneumococcal-conjugate-vaccine-pneu-c-13-in-addition-to-23-valent-pneumococcal-polysaccharide-vaccine-pneu-p-23-immunocompetent-adults-65-years-and-older-interim-recommendation/figure-2-eng.gif)
Update on the use of 13-valent pneumococcal conjugate vaccine (PNEU-C-13) in addition to 23-valent pneumococcal polysaccharide vaccine (PNEU-P-23) in immunocompetent adults 65 years of age and older – Interim Recommendation - Canada.ca
![Update on the use of pneumococcal vaccines in adults 65 years of age and older – A Public Health Perspective - Canada.ca Update on the use of pneumococcal vaccines in adults 65 years of age and older – A Public Health Perspective - Canada.ca](https://www.canada.ca/content/dam/phac-aspc/images/services/publications/healthy-living/update-on-the-use-of-pneumococcal-vaccines-in-adult/update-on-the-use-of-pneumococcal-vaccines-in-adult-eng.jpg)
Update on the use of pneumococcal vaccines in adults 65 years of age and older – A Public Health Perspective - Canada.ca
![of maxillary sinus pneumatization and their averages at the different... | Download Scientific Diagram of maxillary sinus pneumatization and their averages at the different... | Download Scientific Diagram](https://www.researchgate.net/publication/262341146/figure/tbl2/AS:669707262763031@1536682062721/of-maxillary-sinus-pneumatization-and-their-averages-at-the-different-anatomic-locations.png)
of maxillary sinus pneumatization and their averages at the different... | Download Scientific Diagram
![Buy Xuancheng 10 Inches Electric Scooter Tire Camera for Xiaomi M365 Scooter Off Road Tyre Wheel Tube Tire for Xiaomi M365 Pro2 at affordable prices — free shipping, real reviews with photos — Joom Buy Xuancheng 10 Inches Electric Scooter Tire Camera for Xiaomi M365 Scooter Off Road Tyre Wheel Tube Tire for Xiaomi M365 Pro2 at affordable prices — free shipping, real reviews with photos — Joom](https://img.joomcdn.net/f2ca09db622c31dab58ae6d4455292ae02e2a2df_original.jpeg)
Buy Xuancheng 10 Inches Electric Scooter Tire Camera for Xiaomi M365 Scooter Off Road Tyre Wheel Tube Tire for Xiaomi M365 Pro2 at affordable prices — free shipping, real reviews with photos — Joom
![IJERPH | Free Full-Text | Predicting the 14-Day Hospital Readmission of Patients with Pneumonia Using Artificial Neural Networks (ANN) | HTML IJERPH | Free Full-Text | Predicting the 14-Day Hospital Readmission of Patients with Pneumonia Using Artificial Neural Networks (ANN) | HTML](https://www.mdpi.com/ijerph/ijerph-18-05110/article_deploy/html/images/ijerph-18-05110-g004.png)
IJERPH | Free Full-Text | Predicting the 14-Day Hospital Readmission of Patients with Pneumonia Using Artificial Neural Networks (ANN) | HTML
![Update on the use of 13-valent pneumococcal conjugate vaccine (PNEU-C-13) in addition to 23-valent pneumococcal polysaccharide vaccine (PNEU-P-23) in immunocompetent adults 65 years of age and older – Interim Recommendation - Canada.ca Update on the use of 13-valent pneumococcal conjugate vaccine (PNEU-C-13) in addition to 23-valent pneumococcal polysaccharide vaccine (PNEU-P-23) in immunocompetent adults 65 years of age and older – Interim Recommendation - Canada.ca](https://www.canada.ca/content/dam/phac-aspc/images/services/publications/healthy-living/update-use-of-13-valent-pneumococcal-conjugate-vaccine-pneu-c-13-in-addition-to-23-valent-pneumococcal-polysaccharide-vaccine-pneu-p-23-immunocompetent-adults-65-years-and-older-interim-recommendation/figure-3-eng.gif)
Update on the use of 13-valent pneumococcal conjugate vaccine (PNEU-C-13) in addition to 23-valent pneumococcal polysaccharide vaccine (PNEU-P-23) in immunocompetent adults 65 years of age and older – Interim Recommendation - Canada.ca
![A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE) - ScienceDirect A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X21010975-gr6.jpg)
A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE) - ScienceDirect
![Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study - The Journal of Heart Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study - The Journal of Heart](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4ad0494c-77c7-4990-b40f-5d0bd2ebd72f/gr1_lrg.jpg)